Newsletter Current page: 8

Dutch growth company Incision is in the process of building a leading online surgical knowledge platform. Hospitals in 18 countries already use Incision’s online offering. With the purchase of OK Learning’s e-learning modules and performance support tool, Incision is expanding its own knowledge platform with more than 50 new interactive courses and several new features. […]

Since mid-May we welcome Sarah Stelzer at SHS. Born and raised in Tübingen, Sarah is a true native of Tübingen. At SHS, she is responsible for PR and marketing. She takes care of press releases, social media contributions, coordinates projects with our portfolio companies and is also the mouthpiece of SHS to the outside world. […]

A few weeks ago, SHS officially became a member of the United Nations PRI Initiative for Responsible Investment, which was founded in 2006. PRI stands for “Principles for Responsible Investment”. Dr. André Zimmermann is an SHS partner and Head of ESG and thus responsible for socially responsible investing at SHS. We talked to him about […]

In addition to patients suffering from depression, people suffering from generalized anxiety disorder or panic disorder can now also get Selfapy’s online courses free of charge on prescription. This makes Selfapy a pioneer in digital healthcare with three approved digital health apps (DiGA). The aim of Selfapy’s courses is to offer help to sufferers until […]

The Swiss company TRI Dental Implants Int. AG officially presented the matrix® implant system with its six patented product features at the hybrid event TRITalks in Zurich on 18 June 2021. matrix® does not require an abutment or cementation and thus represents a technical revolution in dental medicine. Key opinion leaders from various countries brought […]

SHS offers students from various disciplines the opportunity to complete an internship during their studies. In this way, SHS gives young, motivated people a practical insight into the areas of growth companies and private equity. SHS sees this as an important contribution to the professional development of future top performers. We were pleased to welcome […]

ESG investing in practice After explaining the topic in principle in Parts 1 and 2 of the series “ESG Investing” and showing how ESG investing is anchored throughout at SHS, today we describe two examples from the SHS portfolio. The “S” in the abbreviation ESG investing stands for “social”. This refers to social goals that […]

The world’s first jaw surgery with a bone incision using the CARLO® laser system from AOT was performed at the Paracelsus Clinic in Munich on 14 May 2021. Prof. Dr. Dr. med. Jürgens, who co-developed the robot-controlled laser surgical system, removed the bone layer by layer – without contact – using a laser during the […]

Surgical services are one of the major cost factors in everyday hospital life. Patients expect excellent results from surgery, and payers expect efficient interventions. It is no secret that there are sometimes considerable differences in quality from clinic to clinic. The Dutch company Incision, in which SHS has a stake, has set itself the goal […]

The high-tech company Crystal GmbH produces and processes diffusion-joined laser crystals, substrates for thin-film applications and optical components, among other things. In the field of crystal processing, Crystal is one of the leading suppliers and an important supplier to the medical technology industry. SHS invested in Crystal from its Fund II and is now handing […]

Dipl.-Ing. Marcus Raguse joined the management team of SHS portfolio company Novo Klinik-Service GmbH in May 2021. Novo offers medical aids and medical technology solutions. The graduate engineer brings with him a great deal of experience and know-how in the healthcare sector and, together with Ulrich Frick, who has been Managing Director since January 2021, […]

The company c-LEcta is one of the world’s leading biotech companies in the field of enzyme production. More than 200 customers in 40 countries, including well-known pharmaceutical companies, rely on the enzyme products from Leipzig. 2020 was a successful year for c-LEcta, in which the 10 million euro mark in turnover was broken for the […]